↓ Skip to main content

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

Overview of attention for article published in Breast Cancer Research, November 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
72 Mendeley